Federated Hermes’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.9K | Sell |
1,709
-434
| -20% | -$3.53K | ﹤0.01% | 1765 |
|
2025
Q1 | $16.8K | Sell |
2,143
-750
| -26% | -$5.89K | ﹤0.01% | 1750 |
|
2024
Q4 | $43.1K | Sell |
2,893
-285
| -9% | -$4.24K | ﹤0.01% | 1707 |
|
2024
Q3 | $48.6K | Buy |
+3,178
| New | +$48.6K | ﹤0.01% | 1668 |
|
2023
Q4 | – | Sell |
-1,095
| Closed | -$19.7K | – | 2179 |
|
2023
Q3 | $19.7K | Sell |
1,095
-38,273
| -97% | -$687K | ﹤0.01% | 1766 |
|
2023
Q2 | $800K | Buy |
39,368
+34,915
| +784% | +$709K | ﹤0.01% | 1210 |
|
2023
Q1 | $81.2K | Buy |
4,453
+2,203
| +98% | +$40.2K | ﹤0.01% | 1690 |
|
2022
Q4 | $46.5K | Buy |
2,250
+126
| +6% | +$2.61K | ﹤0.01% | 1721 |
|
2022
Q3 | $56K | Buy |
+2,124
| New | +$56K | ﹤0.01% | 1658 |
|
2022
Q2 | – | Sell |
-3,541
| Closed | -$111K | – | 2255 |
|
2022
Q1 | $111K | Sell |
3,541
-10,137
| -74% | -$318K | ﹤0.01% | 1651 |
|
2021
Q4 | $553K | Buy |
13,678
+8,205
| +150% | +$332K | ﹤0.01% | 1455 |
|
2021
Q3 | $191K | Buy |
5,473
+5,217
| +2,038% | +$182K | ﹤0.01% | 1669 |
|
2021
Q2 | $7K | Sell |
256
-189,137
| -100% | -$5.17M | ﹤0.01% | 2011 |
|
2021
Q1 | $5.32M | Buy |
189,393
+188,881
| +36,891% | +$5.3M | 0.01% | 836 |
|
2020
Q4 | $13K | Sell |
512
-116,773
| -100% | -$2.96M | ﹤0.01% | 1950 |
|
2020
Q3 | $2.01M | Buy |
117,285
+65,060
| +125% | +$1.11M | ﹤0.01% | 985 |
|
2020
Q2 | $1.29M | Sell |
52,225
-45,182
| -46% | -$1.12M | ﹤0.01% | 1155 |
|
2020
Q1 | $1.35M | Buy |
97,407
+91,309
| +1,497% | +$1.27M | ﹤0.01% | 1015 |
|
2019
Q4 | $62K | Sell |
6,098
-407
| -6% | -$4.14K | ﹤0.01% | 1719 |
|
2019
Q3 | $59K | Sell |
6,505
-82
| -1% | -$744 | ﹤0.01% | 1704 |
|
2019
Q2 | $53K | Buy |
6,587
+840
| +15% | +$6.76K | ﹤0.01% | 1667 |
|
2019
Q1 | $72K | Buy |
5,747
+2,038
| +55% | +$25.5K | ﹤0.01% | 1622 |
|
2018
Q4 | $40K | Sell |
3,709
-232
| -6% | -$2.5K | ﹤0.01% | 1682 |
|
2018
Q3 | $55K | Buy |
+3,941
| New | +$55K | ﹤0.01% | 1725 |
|